- Aktuelle Seite:
-
Home
- Wechselwirkungen mit Substitutionsmitteln
Potenziell inadäquate Medikation für ältere Menschen: PRISCUS 2.0 - Erste Aktualisierung der PRISCUS-Liste
Potentially inadequate medications in the elderly: PRISCUS 2.0—first update of the PRISCUS list
Mann, Nina-Kristin; Mathes, Tim; Sönnichsen, Andreas; Pieper, Dawid; Klager, Elisabeth; Moussa, Mahmoud; Thürmann, Petra A.
Dtsch Arztebl Int 2023; 120: 3-10; DOI: 10.3238/arztebl.m2022.0377
https://www.aerzteblatt.de/archiv/229048/Potenziell-inadaequate-Medikation-fuer-aeltere-Menschen-PRISCUS-2-0
A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity.
Traver EC, Heil EL, Schmalzle SA.
Open Forum Infect Dis. 2022 Jul 1;9(7):ofac331. doi: 10.1093/ofid/ofac331. PMID: 35899282; PMCID: PMC9310287.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310287/
Identifying clinically relevant drug-drug interactions with methadone and buprenorphine: a translational approach to signal detection.
Miano TA, Wang L, Leonard CE, Brensinger CM, Acton EK, Dawwas GK, Bilker WB, Soprano SE, Pham Nguyen TP, Woody G, Yu E, Neuman M, Li L, Hennessy S.
Clin Pharmacol Ther. 2022 Jul 26. doi: 10.1002/cpt.2717. Epub ahead of print. PMID: 35881659.
Abstract
https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2717
New app shows how cannabinoids could interact with other medications
A new web-based application developed by Penn State researchers could help pharmacists and other health care providers improve patient safety by reducing unintended interactions between medical and recreational marijuana and cannabidiol (CBD) products and other medications. Penn State College of Medicine researchers said that medical marijuana and CBD have become more accessible to consumers through local retail stores, pharmacies or even by illicit means, and that these products may affect the metabolism of other medications. (Pennsylvania State University, USA, 06.04.2022)
https://medicalxpress.com/news/2022-04-app-cannabinoids-interact-medications.html
Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review.
Lopera V, Rodríguez A, Amariles P.
J Clin Med. 2022 Feb 22;11(5):1154. doi: 10.3390/jcm11051154. PMID: 35268245; PMCID: PMC8911401.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911401/
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.
Lenoir C, Niederer A, Rollason V, Desmeules JA, Daali Y, Samer CF.
CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):30-43. doi: 10.1002/psp4.12730. Epub 2021 Nov 17. PMID: 34791831; PMCID: PMC8752107.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752107/
Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions
Shamema Nasrin, Christy J.W. Watson, Yadira X Perez-Paramo and Philip Lazarus
Drug Metabolism and Disposition December 2021, 49 (12) 1070-1080; DOI: doi.org/10.1124/dmd.121.000442
https://dmd.aspetjournals.org/content/49/12/1070
Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites
Shamema Nasrin, Christy J. W. Watson, Keti Bardhi, Gabriela Fort, Gang Chen and Philip Lazarus
Drug Metabolism and Disposition December 2021, 49 (12) 1081-1089; DOI: doi.org/10.1124/dmd.121.000530
https://dmd.aspetjournals.org/content/49/12/1081
Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study.
Bart G, Giang LM, Yen H, Hodges JS, Brundage RC.
Drug Alcohol Depend. 2021 Oct 1;227:109025. doi: 10.1016/j.drugalcdep.2021.109025. Epub 2021 Sep 1. PMID: 34482033.
Abstract
https://pubmed.ncbi.nlm.nih.gov/34482033/
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD.
Berger O, Rector K, Meredith J, Sebaaly J.
Ment Health Clin. 2021 Jul 16;11(4):231-237. doi: 10.9740/mhc.2021.07.231. PMID: 34316418; PMCID: PMC8287868.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287868/
Adverse drug reactions with naltrexone: Experience from an addiction treatment center.
Sarkar S, Addagadda SS, Bhatia G, Chadda RK.
Indian J Psychiatry. 2021 Mar-Apr;63(2):206-207. doi: 10.4103/psychiatry.IndianJPsychiatry_94_20. Epub 2021 Apr 14. PMID: 34194072; PMCID: PMC8214125.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214125/
Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance.
Ershad M, Cruz MD, Mostafa A, Mckeever R, Vearrier D, Greenberg MI.
J Addict Med. 2020 Mar/Apr;14(2):172-174. doi: 10.1097/ADM.0000000000000535. PMID: 31206401.
Abstract
https://pubmed.ncbi.nlm.nih.gov/31206401/
Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.
Vázquez M, Guevara N, Maldonado C, Guido PC, Schaiquevich P
Biomed Res Int. 2020 Aug 13;2020:3902740. doi: 10.1155/2020/3902740. PMID: 32855964; PMCID: PMC7443220.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443220/
Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route.
Kharidia, J., Howgate, E.M., Laffont, C.M., Liu, Y. and Young, M.A. (2021),
Clinical Pharmacology in Drug Development. doi.org/10.1002/cpdd.934
https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.934
Opioids and antidepressants: which combinations to avoid.
Perananthan V, Buckley NA.
Aust Prescr 2021;44:41-4. doi.org/10.18773
https://www.nps.org.au/australian-prescriber/articles/opioids-and-antidepressants-which-combinations-to-avoid
Drug-Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C.
Gao LH, Nie QH, Zhao XT.
Int J Gen Med. 2021 Jan 28;14:289-301. doi: 10.2147/IJGM.S283910. PMID: 33536776; PMCID: PMC7850569.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850569/
Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes.
Gnanapandithan K, Karthik N, Gerber J.
Clin Pract. 2021 Feb 7;11(1):101-105. doi: 10.3390/clinpract11010015. PMID: 33562182; PMCID: PMC7931031.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931031/
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs.
Berger FA, van der Sijs H, van Gelder T, Kuijper AFM, van den Bemt PMLA, Becker ML.
Int J Med Inform. 2021 Jan;145:104329. doi: 10.1016/j.ijmedinf.2020.104329. Epub 2020 Nov 4. PMID: 33181445.
https://www.sciencedirect.com/science/article/pii/S1386505620302847?via%3Dihub
Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents.
Hong J, Wright RC, Partovi N, Yoshida EM, Hussaini T.
J Clin Transl Hepatol. 2020 Sep 28;8(3):322-335. doi: 10.14218/JCTH.2020.00034. Epub 2020 Jul 30. PMID: 33083256; PMCID: PMC7562806.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562806/
Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol.
Madden K, Tanco K, Bruera E. Clinically
Pediatrics. 2020;145(6):e20193256. doi:10.1542/peds.2019-3256
Abstract
https://pubmed.ncbi.nlm.nih.gov/32444381/
Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions.
Brown, J.D.
J. Clin. Med. 2020, 9, 919.
https://www.mdpi.com/2077-0383/9/4/919/htm
Leberzirrhose: Empfehlungen zur sicheren Anwendung von Arzneimitteln
Berlin – Eine Leberzirrhose bei einem Patienten kann bekanntlich den Stoffwechsel und die Dosis-Wirkungsbeziehung von Arzneimitteln verändern und das Risiko von Nebenwirkungen erhöhen. Eine niederländische Arbeitsgruppe hat nun evidenzbasierte Empfehlungen für den Einsatz und die Dosierung zahlreicher praxisrelevanter Arzneimittel bei Leberzirrhose erarbeitet. (aerzteblatt.de, 04.02.2020)
https://www.aerzteblatt.de/nachrichten/109152/Leberzirrhose-Empfehlungen-zur-sicheren-Anwendung-von-Arzneimitteln
Direct‐acting antivirals interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients.
Ing Lorenzini, K, Girardin, F.
Liver Int. 2020; 40: 32– 44. doi.org/10.1111/liv.14283
https://onlinelibrary.wiley.com/doi/full/10.1111/liv.14283
Wechselwirkungen mit HCV-DAA-Medikamenten – Update on hep-druginteractions.org
We have added some new comedications to the interaction checker, at the request of some of our users. You can now look up interactions with alcohol, cannabidiol (CBD), carfentanil, clofazimine, heroin and mesna. (The University of Liverpool’s HEP Drug Interactions Checker, UK, 06.01.2020)
https://hep-druginteractions.org/checker
Improving Recognition and Reporting of Adverse Drug Reactions in the NICU: A Quality Improvement Project.
Cammack B, Oschman A, Lewis T.
Pediatr Qual Saf. 2019 Aug 30;4(5):e203. doi: 10.1097/pq9.0000000000000203.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831056/
Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients.
Ing Lorenzini K, Girardin F.
Liver Int. 2019 Oct 26. doi: 10.1111/liv.14283.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31654604
Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation.
Ji B, Liu S, Xue Y, He X, Man VH, Xie XQ, Wang J.
Drugs R D. 2019 Sep;19(3):297-305. doi: 10.1007/s40268-019-00282-3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738369/
Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance.
Ershad M, Cruz MD, Mostafa A, Mckeever R, Vearrier D, Greenberg MI.
J Addict Med. 2019 Jun 13. doi: 10.1097/ADM.0000000000000535.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31206401
Improving the use of methadone for drug users with tuberculosis to prevent withdrawal
Drug users on methadone programmes who contract tuberculosis (TB) should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial by pharmacy researchers at Aston University in partnership with drugs charity Addaction. (medicalxpress.com, 21.05.2019)
https://medicalxpress.com/news/2019-05-methadone-drug-users-tuberculosis.html
The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study.
Badhan RKS, Gittins R, Al Zabit D.
Drug Alcohol Depend. 2019 May 16. pii: S0376-8716(19)30145-0. doi: 10.1016/j.drugalcdep.2019.03.013.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31122724
Seite 1 von 2